Login / Signup

Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology.

Greta CarraraLisa ArgnaniAnna ZanettiA ZabottiAlen ZabottiGian Domenico SebastianiMarco SebastianiAnd Carlo Alberto Scirè
Published in: Scandinavian journal of rheumatology (2022)
Among RA patients failing a first TNFi, switching is associated with marginally better persistence, in particular for ABA and RTX, with only marginal differences in patients on concurrent csDMARDs.
Keyphrases